Downloads

Table of contents

To view and print the document you may need to install the latest version of the free Acrobat Reader software. If you do not currently have the latest version please click here.


Carl Zeiss Meditec

Company Intelligence Report

32

£295 / $515 / €370

Online, PDF

Carl Zeiss Meditec AG (CZM) is a leading medical technology company that has been active in the optical sector for more than 160 years. The company operates under three business units – the Ophthalmic Systems and Surgical Ophthalmology units comprise the company’s activities in the ophthalmic market; Ophthalmic Systems includes medical laser and diagnostic systems, and Surgical Ophthalmology combines the company’s activities in the field of intraocular lenses (IOLs) and consumables. The third business unit is Microsurgery, which comprises CZM’s activities in the field of neuro, ear, nose and throat surgery (surgical microscopes), surgical visualisation solutions and intraoperative radiation therapy.

Between 2005 and 2007, three strategic acquisitions played a key part in expanding CZM’s activities. In 2005, the purchase of Ioltech added a range of IOLs and consumables to CZM's product portfolio; Carl Zeiss Surgical, the world's leading provider of surgical microscopes, added visualisation solutions for ophthalmic, neuro and ENT surgery to the CZM range in 2006; and in 2007, the acquisition of Acri.Tec in Germany expanded CZM's offering in the ophthalmic surgery segment.

CZM is based in Jena, Germany, and has principal subsidiaries in Germany, the US, Japan, Spain and France. In the fiscal year ended 30th September 2009, the company generated revenues of EUR640.1 million and employed more than 2,140 people.

Sixty-five per cent of CZM shares are held by Carl Zeiss, a manufacturer of optical and opto-electronics systems. The remaining 35% of the shares are in free float.


This company report provides

Overview
  • Key contact information
  • Introduction to the company and its current activities
  • Summary of its financial performance
  • Who are the company’s major competitors?
  • Key recent events in an “at a glance” format
Financial Review
  • Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
  • Table providing in-depth five-year financial analysis
  • Employee data, including breakdown by company division and geographic location

Strategic Focus
Investigates the company’s aims and its areas of focus

Products
Core product areas, key brands, product approvals and launches
Research and Development
  • How much has been invested in R&D?
  • Where is the research based?
  • What alliances and agreements does the company have and with whom?

Manufacturing and Distribution
  • Identifying the company’s manufacturing locations
  • Sales and marketing facilities

Agreements
  • With whom has the company reached agreements and what do they involve?
  • Key contracts awarded

Mergers, Acquisitions, Minority Investments and Divestments

Litigation

Key Corporate Events

The report was produced as part of Medical Device Companies Analysis (MDCA). For more information on MDCA, click here.